The American Journal of Managed Care

Dr Gary Lyman: Uptake of Filgrastim vs Pegfilgrastim Biosimilars

Gary Lyman, MD, MPH, an oncologist and hematologist, compares the uptake of filgrastim biosimlars with pegfilgrastim biosimilars. Gary Lyman, MD, MPH, is an oncologist, hematologist, and public health ...
Reuters

FDA panel unanimously backs Novartis' copy of Amgen's Neupogen

(Reuters) - A panel to the U.S. Food and Drug Administration unanimously backed the approval of Novartis AG's copy of Amgen Inc's blockbuster cancer drug Neupogen, setting the stage for the ...
BioWorld

FDA grants approvals to Stelara, Neupogen, Eylea biosimilars

The U.S. FDA approved three biosimilar products from Samsung Bioepis Co. Ltd., Tanvex Biopharma Inc. and Formycon AG as follow-on biologics to Stelara (ustekinumab), Neupogen (filgrastim) and Eylea ...
Reuters

Insmed drug shows equivalence to Amgen's Neupogen

NEW YORK, July 10 (Reuters) - Insmed Inc said on Thursday its version of Amgen Inc's drug Neupogen, for boosting white blood cells, showed equivalence in a small study, moving Insmed closer to ...